Treatments & Interventions
Interferon alfacon-1
substance
Alitretinoin
substance
Interferon gamma-1b
substance
Interferon alfa-2a
substance
Interferon alfa-2b
substance
Vinblastine
substance
Vinblastine sulphate
substance
Etoposide
substance
Dactinomycin
substance
Paclitaxel
substance
Peginterferon alfa-2b
substance
Daunorubicin hydrochloride liposome
substance
Peginterferon alfa-2a
substance
Albumin bound paclitaxel
substance
Etoposide phosphate
substance
Daunorubicin citrate liposome
substance
Doxorubicin hydrochloride pegylated liposome
substance
Research Evidence
Peer-reviewed studies linked via MeSH term "Sarcoma, Kaposi" from the MEDLINE/PubMed database.
Research data from MEDLINE/PubMed
Signs & Symptoms
Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.
Related Conditions
Quick Facts
- SNOMED CT
- 109385007
- UMLS CUI
- C0036220
- Fully Specified Name
- Kaposi's sarcoma (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- HPO Phenotypes
- 26
- Known Treatments
- 17
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.